Kidney Tumor Program
The Cancer Center at Beth Israel Deaconess Medical Center is a world-class leader in kidney cancer treatment and research. Among the first in New England to offer a multidisciplinary team dedicated to kidney cancer, BIDMC is:
- The lead site for the Dana-Farber/Harvard Cancer Center (DF/HCC) Kidney Cancer Program.
- The lead recipient of the only National Cancer Institute-funded kidney cancer SPORE grant.
For an overview of kidney cancer, and information on current medical therapy, new surgical techniques, future treatments, how to be a more informed patient, and other topics, watch our video presentations.